Skip to content

Association of SCFAs with Emotional Integration Dysfunction in MDD via the Gut-Brain Axis: An ERP and Multi-Omics Study

Association of SCFAs with Emotional Integration Dysfunction in MDD via the Gut-Brain Axis: An ERP and Multi-Omics Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118243
Enrollment
Unknown
Registered
2026-02-03
Start date
2025-09-07
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder

Interventions

Depressive Disorder Group:No intervention
Healthy Control Group:No intervention

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for depressive disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (MDD group). 2.Undergo screening via semi-structured clinical interviews to exclude subjects with psychiatric disorders (HC group). 3.Be of Chinese Han ethnicity, with no restrictions on gender. 4.Aged 18–65 years old and right-handed. 5.Have an educational level of primary school or above. 6.Be able to undergo examinations including electroencephalography (EEG), blood sampling, and fecal sample collection. 7.Have not taken prebiotics, probiotics, or antibiotics within one month prior to enrollment.

Exclusion criteria

Exclusion criteria: 1.Comorbidities of other psychiatric disorders (e.g., bipolar disorder, schizophrenia, substance dependence), or poorly controlled severe physical illnesses such as coronary heart disease and thyroid dysfunction. 2.A history of craniocerebral trauma leading to loss of consciousness, or a history of epilepsy. 3.Presence of uncorrectable visual or auditory impairment that cannot be ameliorated to a basically normal level. 4.Presence of obvious finger motor dysfunction (unable to operate a computer mouse). 5.Women who are pregnant or lactating, or individuals who are planning pregnancy or child-rearing. 6.Having received electroconvulsive therapy (ECT)/modified electroconvulsive therapy (MECT) within the past 6 months. 7.A history of allergies to electrode patches, or a phobia of blood or needle sticks. 8.Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Electroencephalography (EEG) detection;Short-Chain Fatty Acids;Gut Microbiota;Blood test;

Secondary

MeasureTime frame
Inflammation-associated Cytokines;HAMA-14?HAMD-17;

Countries

China

Contacts

Public ContactXia Wenjuan

Wuxi Mental Health Center

xwj18715011167@163.com+86 510 8275 5810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026